David J. Cole, M.D. McKoy Rose Professor and Chair MUSC Department of Surgery
On behalf of the faculty and staff in the MUSC Department of Surgery, I would like to extend a warm welcome to you. Building on a long standing tradition of excellence in patient care and teaching, the Department has been a key part of a remarkable ongoing institutional transformation that is unprecedented in its history.
Our mission is: To provide patient care recognized for excellence integrated with innovative research which leads to the advancement of medical science and state of the art training for our surgeons and future physicians. Our clinical programs are well recognized for excellence and continue to grow with the addition of the state of the art facilities provided the opening of Ashley River Towers in 2008. Recent examples of recognized clinical excellence include: Our congenital heart surgery program has been recognized as among the world's best based on outcomes with our cardiac transplant program has recently ranked number one in the Southeast and number two in the United States. We have a nationally recognized expertise in the surgical management of pancreatic diseases and have performed over 35 autologous islet cell transplants for total pancreatectomy patients in the past year with the presence of the new Center for Cellular Therapy. Our Transplant Surgery program has been in the top five nationally based on UHC outcomes metrics for the past three years running. In addition to these highlights, we are a designated Center of Excellence in Bariatric Surgery and look forward to achieving ACS Center of Excellence status for our Level I Trauma Center within the next year.
As a result of a decade of growth, we now have outstanding research efforts in both clinical and basic science in the areas of tumor immunology, cardiothoracic surgery, molecular biomarkers, transplant surgery, and outcomes research. Annual extramural NIH funding for these laboratories exceeded 3.1 million in 2010 which now places us 35th nationally. Teaching has always been a priority and is reflected in the fact that our students continually perform above the national norms and MUSC Golden Apple Awards for excellence in teaching have gone to a disproportionate number of our faculty, residents, and staff for over a decade.
We are dedicated to excellence, and look toward the future with excitement. It is not enough to be providers of excellent patient care; we must aspire to be the ones who will shape the direction of patient care now and in the future. We have the opportunity to think and act at a new level of excellence and expertise with exciting new intra- and inter-institutional programs, nationally prominent faculty, and health initiatives which will have an increasingly regional and national impact. New programs such as regenerative medicine translational research initiatives, development of statewide telemedicine networks, autologous pancreatic islet cell transplantation, an innovative laparoscopic teaching center of excellence, a minimally invasive pediatric surgery program, cutting edge cancer immunotherapy trials and groundbreaking cardiac diagnostics are examples of changes that will continue to reshape our department and allow us to continue to build strong relationships within the State of South Carolina and provide academic leadership at a national level.
David J. Cole, M.D. McKoy Rose Professor and Chair MUSC Department of Surgery